U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07153809) titled 'Fecal Microbiota Transplantation (FMT) in Patients With Moderate to Severe Acute Pancreatitis' on Sept. 07, 2024.
Brief Summary: This study is a randomized, double-blind and placebo-controlled study. The purpose of this study is to evaluate the efficacy and safety of FMT in patients with moderate to severe acute pancreatitis.
Study Start Date: Oct. 12, 2024
Study Type: INTERVENTIONAL
Condition:
Acute Pancreatitis
Severe Acute Pancreatitis
Intervention:
PROCEDURE: FMT
FMT bacterial solution will be injected through a nasojejunal nutrition tube once a day for five days.
PROCEDURE: Placebo
Physiological saline placebo will be ...